| 000 | 01517 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515154613.0 | ||
| 264 | 0 | _c20090212 | |
| 008 | 200902s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/sj.bjc.6604868 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarnadas, A | |
| 245 | 0 | 0 |
_aExemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cFeb 2009 |
||
| 300 |
_a442-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAndrostadienes _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAromatase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aGil, M | |
| 700 | 1 | _aGonzález, S | |
| 700 | 1 | _aTusquets, I | |
| 700 | 1 | _aMuñoz, M | |
| 700 | 1 | _aArcusa, A | |
| 700 | 1 | _aPrieto, L | |
| 700 | 1 | _aMargelí-Vila, M | |
| 700 | 1 | _aMoreno, A | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 100 _gno. 3 _gp. 442-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6604868 _zAvailable from publisher's website |
| 999 |
_c18603253 _d18603253 |
||